Coinfection (HCV/HGV)

Evidence Suggests Hepatitis G Infection Does Not Worsen Hepatitis C Disease

Published in Medical Letter on the CDC and FDA, June 23rd, 1997

A study conducted in conjunction with the U.S. Centers for Disease Control and Prevention (CDC) offers further evidence that hepatitis G virus coinfection does not worsen the course of hepatitis C virus-related disease.

Researcher T.L. Yashina and colleagues found, however, that hepatitis G virus (HGV) infection was significantly associated with hepatitis C virus (HCV).

HGV and GB virus C (GBV-C) are parenterally transmitted agents which may be involved in the etiology of non-A-E hepatitis. The nucleotide sequences of the NS3 regions of HGV and GBV-C are 85 percent identical and the amino acid sequences are 100 percent identical, suggesting that HGV...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1997-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry